FDA Approves $200 Insulin Cap Relief Program
For millions of Americans living with diabetes, the Insulin Cap Program USA 2025 is a beacon of hope, promising to make insulin more affordable starting January 2025. Approved by the FDA, this initiative caps out-of-pocket insulin costs at $200 per month for eligible patients, building on the Inflation Reduction Act’s $35 cap for Medicare beneficiaries. … Read more